COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

The pandemic's impact on statin prescriptions

The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included more than 20,000 patient encounters.

Thumbnail

A closer look at COVID-19's initial impact on cardiovascular care

Low-income countries were hit especially hard by the pandemic. 

Thumbnail

Practice interruptions skyrocketed in April 2020 due to COVID-19

The pandemic also seems to have led to many older physicians leaving their jobs altogether. 

money dollars payment counting

HHS announces $25.5 billion in COVID-19 funding for providers

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

Higher total cholesterol and ApoB levels may increase a person's COVID-19 risk

To limit any potential bias, the study's authors explored data from two different sources. 

Revealed: Why severe COVID-19 infections are more common in people with diabetes

Specialists at the University of Michigan hope their findings can help patients receive an effective treatment early on in their infection. 

Specialists explore relationship between COVID-19 and heart failure, highlighting importance of vaccination

"The rise of the delta variant of COVID-19 is a reminder that this pandemic is not over," the president of the Heart Failure Society of America said in a statement. 

Metoprolol shows promise as an effective (and cheap) treatment for critically ill COVID-19 patients

The medication, commonly used to treat cardiovascular disease, was associated with no side effects in a new analysis out of Spain. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.